1 Huge Opportunity Salesforce and Philips Are Attacking

Salesforce and Philips just announced an ambitious new partnership to bring cloud-based telehealth to the masses. Here’s how the deal with benefit both companies.

Jun 28, 2014 at 7:47AM

Cloud computing giant Salesforce (NYSE:CRM) recently launched an ambitious telehealth collaboration with Dutch conglomerate Koninklijke Philips (NYSE:PHG).

Philips' medical monitoring devices will send biometric data to mobile apps, which will then relay the data to Salesforce's Salesforce1 Platform for analysis. Philips will launch two apps for the platform, eCareCoordinator and eCareCompanion, and open up its APIs for third-party developers to create additional mobile apps. The ultimate goal is to help medical professionals in hospitals monitor the daily health of hundreds of patients at home.


Philips' monitoring devices. Source: Philips

If Salesforce and Philips' partnership takes off, it would mark a big leap forward in merging telehealth, which has mainly focused on one-on-one remote care, with cloud-based services.

Why Salesforce wants to connect hospitals to the cloud
Salesforce is a subscription-based customer relationship management (CRM) service that helps businesses organize and analyze contacts, reports, and accounts over the cloud.

This makes it an attractive alternative to storing data on on-site servers, which are expensive to maintain and prone to failure. Last quarter, Salesforce's subscription and support revenues, which account for 93% of its top line, soared 36% year over year to $1.15 billion.

Recognizing the potential of the company's CRM platform in health care, Peter Gassner, Salesforce's former senior VP of technology, and Matt Wallach, the former GM of pharmaceuticals and biotechnology at Siebel Systems (now part of Oracle), founded Veeva Systems (NYSE:VEEV) in 2007.

Veeva uses Salesforce's CRM platform to track prescriptions, clinical trials, regulatory filings, and industry regulations for drug companies. In March, Veeva agreed to pay Salesforce annual payments that will eventually equal or exceed a total of $500 million to maintain their existing partnership through 2025.

Through Veeva, Salesforce gained a foothold in the biotech and pharmaceutical industries. Through its partnership with Philips, it can extend that reach into hospitals and homes as well. During a recent webcast, Salesforce CEO Marc Benioff noted that the telehealth platform with Philips could eventually connect to consumer-facing health data platforms like Apple's HealthKit, Google (NASDAQ:GOOG) (NASDAQ:GOOGL) Fit, and Samsung's SAMI.

In other words, if those three companies tie together the fragmented market of wearables, devices, and apps, Salesforce could potentially swoop in and connect all of those services to its subscription-based cloud.

Why Philips craves growth in health care
Partnering with Salesforce is only one way that Philips intends to connect its medical devices to the cloud.

Last October, Philips partnered with Accenture to launch a proof-of-concept project for Google Glass, which displayed vital signs and data from a patient's EHR (electronic health record) on Glass' heads-up display. Although the system hasn't been tested on real patients in a hospital environment yet, it proved that Philips' IntelliVue patient monitors could effectively retrieve data from the cloud.

Partnering with Accenture and Salesforce will put Philips at the forefront of three rapidly growing industries -- telehealth, mobile health (mHealth), and enterprise cloud computing. IHS expects that the U.S. telehealth market will grow from $240 million today to $1.9 billion in 2018. Transparency Market Research forecasts that the mHealth market will grow to $8.03 billion by 2019. Meanwhile, the global cloud computing market is expected to grow at a compound annual growth rate of 36% to $19.5 billion by 2016, according to 451 Research.

When we consider that Philips' Healthcare segment, its largest business, posted a 2% year-over-year decline in comparable sales last quarter, it's easy to see why Philips is so interested in tethering its monitoring devices to the cloud.

Connecting bodies to the cloud
In 2013, 190 million patients worldwide were monitored by Philips monitors. 40 million babies were monitored by Philips' fetal monitors. If Philips and Salesforce's partnership is fruitful, those monitors could connect to other medical devices, EHRs, and smartphone apps, completely connecting patients to the Internet of Things for around-the-clock monitoring.

This would be a big benefit to companies, hospitals, and insurers. The margin of medical error could decrease dramatically, and medical practices would earn more government subsidies for achieving "meaningful use" standards under the HITECH Act. Data breaches exposing patient records would fall dramatically as records are moved to cloud-based services like Salesforce, helping practices remain HIPAA-compliant while using telehealth services. Insurers would have to pay less for ER visits and hospital readmissions.

The Foolish takeaway
Salesforce's partnership with Philips could just be one of many cross-industry deals which help medical device makers connect their devices to the cloud. Therefore, investors in both the tech and health care industries should keep an eye on how these companies intend to profit from the growth of the telehealth, mHealth, and cloud computing industries in the near future.

Leaked: A huge new opportunity
The best investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool’s new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Leo Sun owns shares of Google (C shares). The Motley Fool recommends Google (A shares), Google (C shares), and Salesforce.com. The Motley Fool owns shares of Google (A shares) and Google (C shares). Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information